Pedro Lichtinger

Pedro is President and CEO of Asterias Biotherapeutics. Prior to that he was the CEO of Optimer Pharmaceuticals, and before that held several key positions with Pfizer from 1995 to 2009, and was an executive of Smith Kline Beecham.  Mr. Lichtinger serves on the board of directors of Sanfer de México.  Mr. Lichtinger holds an MBA from the Wharton School of Business and an Industrial Engineering degree from the National University of Mexico.